- Generic name
- Linagliptin + Metformin Hydrochloride
- Strength
- 2.5 mg + 500 mg
- Dosage form
- Tablet
- Manufactured by
- One Pharma Ltd.
Lindela-M 2.5/500 Tablet Tablet
About Lindela-M 2.5/500 Tablet
Lindela-M 2.5/500 Tablet comes as a tablet with 2.5 mg + 500 mg of Linagliptin + Metformin Hydrochloride, from One Pharma Ltd. It is added to a proper diet and exercise plan to improve blood sugar control when treatment with both linagliptin and metformin is considered appropriate.
There are 31 brands of Linagliptin + Metformin Hydrochloride listed in Bangladesh. The lowest listed price is Linatin M 2.5 mg + 500 mg Tablet at ৳ 7.00 per unit.
What is Lindela-M 2.5/500 Tablet?
Lindela-M 2.5/500 Tablet is a tablet from One Pharma Ltd., with the generic name Linagliptin + Metformin Hydrochloride. It contains linagliptin and metformin hydrochloride in a single tablet. Only a registered doctor can decide whether it suits a particular person, and the dose and course are set by the doctor. The dose and course are set by your doctor based on your needs.
Uses of Lindela-M 2.5/500 Tablet
It is added to a proper diet and exercise plan to improve blood sugar control when treatment with both linagliptin and metformin is considered appropriate. It is not a replacement for lifestyle measures. It is chosen when treatment with both linagliptin and metformin hydrochloride together is suitable for the person. Ask your doctor whether it is right for your condition.
How to use Lindela-M 2.5/500 Tablet
Swallow the tablet as directed. Lindela-M 2.5/500 Tablet is taken by mouth. Swallow the tablet with water. Swallow the tablet as your doctor or pharmacist advises. If you miss a dose, ask your doctor or pharmacist what to do. The dose and course are set by the doctor for each person, so follow the instructions given to you and do not change them yourself.
Side effects of Lindela-M 2.5/500 Tablet
The most common side effects reported with this combination are nasopharyngitis and diarrhea. Low blood sugar (hypoglycemia) is more common when it is taken with sulfonylureas. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor promptly if you suspect acute pancreatitis, which has been reported after marketing.
Safety and precautions
This combination is not for everyone. There are no adequate studies of this combination in pregnant women, so it should be used in pregnancy only if clearly needed, and caution is advised during breastfeeding. Your doctor may stop the medicine temporarily in these situations. Tell your doctor about kidney problems, surgery, contrast imaging or other medicines first.
Frequently asked questions
Why is Lindela-M 2.5/500 Tablet prescribed?
It is added to a proper diet and exercise plan to improve blood sugar control when treatment with both linagliptin and metformin is considered appropriate. It is not a replacement for lifestyle measures.
How do I use Lindela-M 2.5/500 Tablet correctly?
Swallow the tablet as directed. Lindela-M 2.5/500 Tablet is taken by mouth.
What are the side effects of Lindela-M 2.5/500 Tablet?
The most common side effects reported with this combination are nasopharyngitis and diarrhea. Low blood sugar (hypoglycemia) is more common when it is taken with sulfonylureas.
Is Lindela-M 2.5/500 Tablet safe for everyone?
This combination is not for everyone. There are no adequate studies of this combination in pregnant women, so it should be used in pregnancy only if clearly needed, and caution is advised during breastfeeding.
Indications
Pharmacology
Metformin Hydrochloride is a biguanide type oral antihyperglycemic drug used in the management of type 2 diabetes. It lowers both basal and postprandial plasma glucose. Its mechanism of action is different from those of sulfonylureas and it does not produce hypoglycemia. Metformin Hydrochloride decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by an increase in peripheral glucose uptake and utilization.
Dosage & Administration
Recommended starting dose: In patients currently not treated with Metformin Hydrochloride, initiate treatment with 2.5 mg Linagliptin and 500 mg Metformin Hydrochloride twice daily.
In patients already treated with Metformin Hydrochloride, start with 2.5 mg Linagliptin and the current dose of Metformin Hydrochloride twice daily.
Patients already treated with Linagliptin and Metformin Hydrochloride, individual components may be switched to this combination containing the same doses of each component.
Linagliptin & Metformin extend release tablet: The dosage of this combination should be individualized on the basis of both effectiveness and tolerability, while not exceeding the maximum recommended total daily dose of Linagliptin 5 mg and Metformin Hydrochloride 2000 mg. this combination should be given once daily with a meal.
Recommended starting dose: In patients currently not treated with metformin, initiate this combination treatment with 5 mg Linagliptin/1000 mg Metformin Hydrochloride extended-release once daily with a meal.
In patients already treated with Metformin, start this combination with 5 mg of Linagliptin total daily dose and a similar total daily dose of Metformin once daily with a meal.
In patients already treated with Linagliptin & Metformin immediate release tablet, switch to extend release tablet containing 5 mg of Linagliptin total daily dose and a similar total daily dose of Metformin once daily with a meal.
5 mg Linagliptin & 1000 mg Metformin Hydrochloride extended-release tablet should be taken as a single tablet once daily. Patients using 2.5 mg Linagliptin & 1000 mg Metformin extended release tablets should take two tablets together once daily.
Interaction
P-glycoprotien/CYP3A4 inducer (i.e. rifampin): The efficacy of this medicine may be reduced when administered in combination.
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects
During controlled clinical trials in healthy subjects, with single doses of up to 600 mg of Linagliptin (equivalent to 120 times the recommended daily dose), there were no dose-related clinical adverse drug reactions.
Overdose of Metformin Hydrochloride has occurred in case of ingestion of amounts greater than 50 grams. Hypoglycemia was reported in approximately 10% of cases, but no causal association with Metformin Hydrochloride has been established. Lactic acidosis has been reported in approximately 32% of Metformin Hydrochloride overdose cases.
Storage Conditions
Alternative brands of Linagliptin + Metformin Hydrochloride
Other brands with the same generic name, cheapest first.
Linatin M Tablet
2.5 mg + 500 mg
Linagliptin + Metformin Hydrochloride
Delta Pharma Limited
৳ 6.86 ৳ 7.00 2% off per unit
Linatin M Tablet
2.5 mg + 850 mg
Linagliptin + Metformin Hydrochloride
Delta Pharma Limited
৳ 7.84 ৳ 8.00 2% off per unit
Adlinameg Tablet
2.5 mg+500 mg
Linagliptin + Metformin Hydrochloride
UniMed UniHealth
৳ 11.76 ৳ 12.00 2% off per unit
Formet-L Tablet
2.5 mg + 500 mg
Linagliptin + Metformin Hydrochloride
Biopharma Ltd.
৳ 11.76 ৳ 12.00 2% off per unit
Carlina-M Tablet
2.5 mg+500 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
৳ 12.74 ৳ 13.00 2% off per unit
Biolina Plus Tablet
2.5 mg+850 mg
Linagliptin + Metformin Hydrochloride
Biogen Pharmaceuticals Ltd.
৳ 13.23 ৳ 13.5 2% off per unit
Adlinameg Tablet
2.5 mg+850 mg
Linagliptin + Metformin Hydrochloride
UniMed UniHealth
৳ 13.72 ৳ 14.00 2% off per unit
Carlina-M Tablet
2.5 mg+850 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
৳ 13.72 ৳ 14.00 2% off per unit
Carlina-M Tablet
2.5 mg+1000 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
৳ 15.68 ৳ 16.00 2% off per unit
Carlina-M 2.5/1000 Tablet
2.5 mg + 1000 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
৳ 15.68 ৳ 16 2% off per unit
Carlina-M 2.5/850 Tablet
2.5 mg + 850 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
Price not listed
Carlina-M FC Tablet Tablet
2.5 mg + 500 mg
Linagliptin + Metformin Hydrochloride
Radiant Pharmaceuticals Ltd.
Price not listed
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.